Surprise Castle
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges - Hardcover

$220.99
Quantity
01

Pay over time for orders over $35.00 with

Offers & Perks

Earn 220 points with this purchase

Added to your rewards balance after checkout.

100 points welcome bonus

Create an account and start with extra points.

Join now
Availability:In StockContributor:Michael S. WolfePublish date:6/13/2016Pages:676
Languages:EnglishPublisher:Academic PressISBN-13:9780128021736ISBN-10:012802173XUPC:9780128021736Book Category:Medical, ScienceBook Subcategory:Pharmacology, Neuroscience, Life SciencesBook Topic:Molecular BiologySize:9.40 x 7.60 x 1.10 inchesWeight:1.544Product ID:SCW3GAH8SF

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer's disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the special challenges related to specific targets and approaches, while presenting a realistic, comprehensive and balanced view of drug discovery and development in this area.

Written by international leaders in the field, the book assesses prospects for the emergence of effective agents and allows readers to better understand the challenges, failures, and future potential for research in Alzheimer's disease. This book is a valuable resource to academic scientists carrying out translational research in Alzheimer's disease, industrial scientists engaged in Alzheimer's drug discovery, executives in biopharmaceutical companies making strategic decisions regarding the direction of internal research and potential outside partnerships, and graduate-level students pursuing courses on Alzheimer's therapeutics.

Languages:EnglishPublisher:Academic PressISBN-13:9780128021736ISBN-10:012802173XUPC:9780128021736Book Category:Medical, ScienceBook Subcategory:Pharmacology, Neuroscience, Life SciencesBook Topic:Molecular BiologySize:9.40 x 7.60 x 1.10 inchesWeight:1.544Product ID:SCW3GAH8SF
Wolfe, Michael S.: - Michael S. Wolfe is the Mathias P. Mertes Professor of Medicinal Chemistry at the University of Kansas. He received his B.S. in chemistry in 1984 from the Philadelphia College of Pharmacy and Science and Ph.D. in medicinal chemistry in 1990 from the University of Kansas. After postdoctoral stints at the University of Kansas (medicinal chemistry) and the NIH (cell biology), he joined the faculty of the University of Tennessee in Memphis in 1994. In 1999, he joined the faculty at Brigham and Women's Hospital and Harvard Medical School in Boston, becoming Professor of Neurology in 2008. Prof. Wolfe's work has focused on understanding the molecular basis of Alzheimer's disease and related disorders, and identifying effective approaches for pharmacological intervention. Awards for his work include the Sato Memorial International Award in bioorganic and medicinal chemistry from the Pharmaceutical Society of Japan (2003), the MetLife Award for Biomedical Research (2008), a Zenith Fellows Award from the Alzheimer's Association (2008), and the Potamkin Prize from the American Academy of Neurology (2009).
Publisher: Academic Press

Contributor(s)

Michael S. Wolfe

Free shipping on orders over $75. Standard shipping takes 3-7 business days. Returns accepted within 30 days of purchase.